Drugs / amustaline
amustaline
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01716923 | Apr 2013 → Jul 2014 | — | Cerus Corporation | Completed | Met primary |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | amustaline | “amustaline (S-303) and glutathione (GSH)” PMID 29498049 ↗ Mar 2018 |
| Known as | AMUSTALINE DIHYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111082 ↗ |
| Known as | S-303 | “amustaline (S-303) and glutathione (GSH)” PMID 29498049 ↗ Mar 2018 |
| Known as | S-303 DIHYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111082 ↗ |
| Known as | S-303.2HCL | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111082 ↗ |
| Modality | Small molecule | — CHEMBL2111082 ↗ |